REGN vs WYY · P/E 14, rev $4.29B vs rev $78.6M
Regeneron Pharmaceuticals Inc (REGN) versus Widepoint C (WYY) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Widepoint C (WYY) is a information technology services company listed on AMEX.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WYY revenue for 2026-06-30 was $78.6M. Net income was $143.4K. Revenue was up 93.7% from 2026-03-31 to 2026-06-30. WYY currently screens at market cap $129.3M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WYY currently screens at market cap $129.3M.
Not investment advice. Open the REGN and WYY stock pages for the full models.
Not investment advice.